AI chatbot education for gynecologic cancer patients
Part of Women’s health & pregnancy clinical trials.
This trial uses an AI chatbot to help educate gynecologic oncology patients about HPV vaccination. It aims to see if the chatbot improves knowledge and vaccination rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a patient at the LA General gynecologic oncology clinic
- You are 18 years or older
- You speak English or Spanish
- You have previously received the HPV vaccine (for the initial chatbot evaluation) or are eligible for it (for the pilot intervention)
- You are willing and able to provide informed consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses a chatbot (a computer program you can chat with) to give female university students information about the HPV vaccine, which helps prevent certain cancers. The goal is to see if the chatbot can improve your awareness of the vaccine, increase your interest in getting it, and help more students actually get vaccinated.
This trial tests a chatbot (a computer program you can chat with) to see if it helps parents learn about the HPV vaccine, feel more positive about it, and actually get their daughters vaccinated. If you join, you'll use the chatbot and answer questions about your thoughts and decisions.
This study tests whether a chatbot can help women feel more confident about the HPV vaccine and reduce hesitancy. It is for women who have not yet received the vaccine.
This trial tests whether an AI chatbot can encourage women to take part in cervical cancer screening. It targets women who have not had a recent Pap test and who did not respond to an invitation letter, aiming to improve participation.
This study tests an AI chatbot that helps patients understand radiation therapy for prostate cancer. If you are starting radiation treatment at Brigham and Women's Hospital, this chatbot may help answer your questions and support you through your care.
This study tests whether a chatbot can help people complete hereditary cancer genetic risk assessment before a gynecology new-patient visit. It may help you understand and organize next steps for genetic testing, if needed.
Hear when a new Gynecologic Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.